
|Articles|February 3, 2022
Analysis of Antibody Drug Conjugates
Author(s)Agilent Technologies, Inc.
This application note describes the drug-to-antibody determination of brentuximab vedotin using a ternary gradient with isopropanol as third channel organic modifier.
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
3
Hyphenated Chromatography Methods: Successes and Remaining Challenges
4
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
5
